Does Rallies show Form 4 insider transactions for WHWK?

Yes. Rallies tracks WHWK insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is WHWK research on Rallies investment advice?

No. Rallies provides research, data, and educational context for WHWK. It does not provide personalized investment advice.

WHWK (Whitehawk Therapeutics, Inc. Common Stock) Stock Analysis - Insider Trades

Whitehawk Therapeutics, Inc. Common Stock (WHWK) is a publicly traded Healthcare sector company. As of May 21, 2026, WHWK trades at $4.17 with a market cap of $210.17M and a P/E ratio of -12.68. WHWK moved +4.18% today. Year to date, WHWK is +66.80%; over the trailing twelve months it is +112.06%. Its 52-week range spans $1.39 to $5.50. Analyst consensus is buy with an average price target of $7.33. Rallies surfaces WHWK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading WHWK stock inside the company?

Recent WHWK insider activity includes Giacobello Scott M. sold 141.60K, Giacobello Scott M. sold 77.00K, BALL BRYAN sold 92.46K, BALL BRYAN sold 26.39K, and BALL BRYAN sold 6.60K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

WHWK Key Metrics

Key financial metrics for WHWK
Metric	Value
Price	$4.17
Market Cap	$210.17M
P/E Ratio	-12.68
EPS	$-0.33
Dividend Yield	0.00%
52-Week High	$5.50
52-Week Low	$1.39
Volume	17
Avg Volume	0
Revenue (TTM)	$7.14M
Net Income	$-20.60M
Gross Margin	89.36%

Recent WHWK Insider Trades

Giacobello Scott M. sold 141.60K (~$584.81K) on Apr 16, 2026.
Giacobello Scott M. sold 77.00K (~$297.22K) on Apr 15, 2026.
BALL BRYAN sold 92.46K (~$336.55K) on Apr 14, 2026.
BALL BRYAN sold 26.39K (~$91.31K) on Apr 13, 2026.
BALL BRYAN sold 6.60K (~$22.62K) on Apr 10, 2026.

Latest WHWK News

Whitehawk Therapeutics Raises $87.5M in Private Placement to Fund ADC Pipeline — May 13, 2026
Whitehawk Reports $123M Cash, Advances Phase 1 Trials, Plans HWK-206 IND — May 7, 2026
Whitehawk Finds 100-Fold MUC16 Expression Advantage, Backs HWK-016 Phase 1 — Apr 10, 2026
Whitehawk Therapeutics Details ADC Pipeline Progress and 2028 Cash Runway — Feb 25, 2026

WHWK Analyst Consensus

5 analysts cover WHWK: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.33.

Common questions about WHWK

Who is trading WHWK stock inside the company?: Recent WHWK insider activity includes Giacobello Scott M. sold 141.60K, Giacobello Scott M. sold 77.00K, BALL BRYAN sold 92.46K, BALL BRYAN sold 26.39K, and BALL BRYAN sold 6.60K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for WHWK?: Yes. Rallies tracks WHWK insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is WHWK research on Rallies investment advice?: No. Rallies provides research, data, and educational context for WHWK. It does not provide personalized investment advice.